Healthpeak Properties (DOC) Stock Analysis & Forecast

Nov 13 close

$19.98−0.14 (−0.7%)

Gekko Brief

AI summaryNov 9 close

Healthpeak's week centers on strong Q3 2026 results, with FFOA and revenues beating estimates on solid outpatient leasing and senior housing growth, prompting the company to raise its full-year FFOA outlook for the third time in 2026. The Q3 guidance revision put the FFO midpoint at $1.77 with a payout ratio improving to 69%. Commentary points to stabilization and leasing momentum in the Lab segment, with buildings near existing campuses targeted to climb from 41% occupancy toward a 9% to 10% stabilized yield. Separately, a stock offering at Janus Living (JAN) will leave Healthpeak affiliates with majority voting power there.

Shares closed at $20.62, up 1.8%, sitting above both the 50-day average of $19.74 and the 200-day average of $19.20, with the 50-day above the 200-day. The GekkoIndex reads 49.7, placing it in the Neutral zone, down 9.2 over the past five readings. Price remains 20.5% below Gekko Fair Value of $25.95.

The next earnings date falls on 1 February 2027, 83 days out and beyond a typical 20-trading-day hold. No insider, Congress, or unusual options activity appears in the current windows, though one billionaire holder and one trailblazer holder are noted. Seasonally, the next 20 trading days have averaged a 2% gain over 5 years, rising in 3 of those years. Analyst coverage from 11 firms shows 1 buy and 10 hold ratings, with a consensus target of $22.95.

Written by AI from the Nov 9, 2026 close and checked automatically against the figures on this page.

Healthpeak Properties price vs fair value

$25.95$19.98Nov ’25May ’26Nov ’26
Close $19.98200-day averageGekko Fair Value $25.95

Healthpeak Properties quick facts

Market cap
$13.78B
P/E ratio
53.3
Forward P/E
169.5
EPS, TTM
$0.35
Revenue, TTM
$2.95B
Profit margin
8.3%
Dividend yield
6.42%
Beta
0.99
Volume
4.82M avg 6.14M
1-year return
+13.3%
Typical daily move
±2.5%
Typical 20-day move
±5%
50-day average
$19.68
200-day average
$19.25
Next earnings
Feb 1
Shares outstanding
689.5M
52-week range
$15.70$22.95

Healthpeak Properties swing-trade checklist

Healthpeak Properties scores 3 supportive, 2 mixed and 0 headwinds across the 5 checklist items with data.

Six things swing traders check before a 20-day hold, read from the latest data.

3 supportive2 mixed0 headwinds

  • Trendsupportive

    Above 50 and 200-day

    Close $19.98 is above the 50-day ($19.68) and 200-day ($19.25) averages, and the 50-day is above the 200-day.

    See the chart
  • GekkoIndexmixed

    54.9, Neutral

    Reading 54.9 is in the Neutral zone.

    See the GekkoIndex
  • Fair valuesupportive

    23.0% below

    Price is 23% below Gekko Fair Value (more than 5% below).

    See fair value
  • Smart moneyno data

    No data

    No insider, Congress or unusual options activity in the window.

    See smart money
  • Earnings risksupportive

    Reports in 78 days

    Next report Feb 1, 2027, 78 days away — outside a typical 20-trading-day hold.

    See earnings
  • Seasonalitymixed

    +1.8% on average

    From this point in the calendar, the next 20 trading days averaged +1.8% over 5 years, rising in 2 of them.

    See seasonality

A description of current data, not a recommendation. How this page works

Healthpeak Properties stock chart and price history

Healthpeak Properties closed at $19.98 on Nov 13, 2026, +13.3% over the past year, inside a 52-week range of $15.70 to $22.95.

Close50-day average200-day averageVolume
Healthpeak Properties share price, past year, with 50-day and 200-day moving averages and volume$16$18$22DecJan 2026FebMarAprMayJunJulAugSepOctNov19.98

Use the left and right arrow keys to read daily values.

Performance Breakdown

1 month
+5.4%
3 months
−2.9%
6 months
+3.2%
1 year
+13.3%
The full DOC chart adds GekkoIndex, insider, options, Congress and hedge fund markers, plus TrendCandles™.Open DOC in Gekko

Follow Healthpeak Properties through every session

Put DOC on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.

Track DOC in GekkoFree for 7 days. No credit card required.

About Healthpeak Properties

Healthpeak Properties works as a real estate investment trust, focusing its efforts on properties tied to medical research and healthcare delivery. Rather than spreading across many property types, it concentrates on real estate that supports the science and treatment side of health, acquiring, managing, and developing buildings suited to those specialized uses. This focus on medical and research-oriented facilities is central to how the company is recognized.

As a REIT, Healthpeak generates income primarily through owning and operating these specialized properties, drawing on rental and related revenue from tenants engaged in healthcare and medical research activities. Its portfolio approach centers on holding higher-quality assets within this niche rather than diversifying into unrelated real estate categories.

Healthpeak Properties is included among the constituents of the S&P 500 index. Its shares trade under the ticker DOC.

Sector
Finance
Website
healthpeak.com

Healthpeak Properties GekkoIndex: the smart money zone

Healthpeak Properties’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 54.9, in the Neutral zone, up 3.7 points over five sessions.

010054.9Neutral

Up 3.7 points over five sessions.

Reading for Nov 13, 2026

What followed past readings in each zone

ZoneReadings5 days10 days20 days50 days
Buying23+0.1%+0.7%+3.4%+2.0%
Accumulation241+0.4%+0.8%+0.3%+1.9%
Neutral (current zone)3640.0%−0.2%0.0%−0.3%
Distribution24−0.3%+0.6%+2.8%+7.5%
Selling3Too few readings yet

Average DOC share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Neutral readings averaged +0.9% over 20 days. Past behaviour doesn’t guarantee future results.

Neutral zone: No clear directional signal. About the five zones →

See every daily GekkoIndex reading plotted over the DOC price, zone by zone.Track DOC in Gekko

Is Healthpeak Properties stock overvalued? Gekko Fair Value

Healthpeak Properties trades 23.0% below Gekko Fair Value of $25.95, so the shares are undervalued on Gekko’s estimate.

Gekko’s own estimate of what Healthpeak Properties shares are worth, recalculated every trading day.

$25.95

Gekko Fair Value, Oct 9, 2026

23.0% Undervalued

At the end of Aug 2026 the price was 29.9% below the estimate.

Gekko Fair ValueShare price, month end
$26$19Aug 2026SepOct 2026

How Gekko Fair Value works →

Gekko Fair Value on every chart, with the gap to price updating daily.Open DOC in Gekko

Healthpeak Properties insider and Congress trading

No open-market insider purchases were filed for Healthpeak Properties, and no Congress trades were disclosed, in the last 90 days.

Plus buybacks, unusual options and fund positions, each dated to when it became public.

Insider buying last 90 days

No open-market insider purchases were filed for DOC in the last 90 days.

From Form 4 filings, dated to when each was filed.

Every DOC insider filing, plotted on the chart in Gekko.Open DOC in Gekko

Congress trades last 90 days

No trades in DOC were disclosed by members of Congress in the last 90 days.

From congressional disclosures, which report amounts as ranges.

Congress disclosures for DOC, plotted on the chart in Gekko.Open DOC in Gekko

Buybacks

Healthpeak Properties has been buying back its own shares.

Latest authorization
$500.0M, Aug 4, 2026
Bought back, quarter ended Sep 30, 2026
$99K
As a share of market cap
0.00%
Trailing four quarters
$101.7M

From company filings.

Hedge funds and billionaires quarter ended Sep 30

1of the funds Gekko tracks holds DOC.

0added0opened1trimmed1sold out
Which funds are on each side, name by name.Unlock in Gekko

Healthpeak Properties earnings: next date and track record

Healthpeak Properties reports on Feb 1, 2027 (78 days away), and beat the EPS estimate in 4 of its last 8 reports.

4 of 8reports beat the EPS estimate
±5.6%average move across the report
3 of 8reports followed by a gain

Share-price move across each report

−3.6%Oct ’24−2.9%Feb ’25−5.3%Apr ’25−7.6%Jul ’25+0.8%Oct ’25−4.6%Feb ’26+19.7%May ’26+0.7%Aug ’26

Last earnings call, Aug 4, 2026 AI summary

What they said
Healthpeak reported strong Q2 2026 results with outpatient medical showing 5% cash re-leasing spreads, 20 bps sequential occupancy growth, and materially lower TIs versus peers. Senior Housing delivered 260 bps occupancy growth and 19% NOI growth, with $1.8B in acquisitions closed since January. The company secured joint ventures with Blackstone and Brookfield, maintains leverage below 5x, and executed a $100M share buyback at sub-$17/share.
Guidance
Management expects outpatient portfolio internal growth to accelerate in 2027, with Senior Housing portfolio doubling in size in 2026. Life science occupancy expected to inflect upward. Capital allocation priorities include pre-leased development, JV acquisitions, and opportunistic life science acquisitions.
ReportedEPSSurpriseRevenueSurpriseMove
Aug 4, 2026$0.08
est $0.03
+184.2%$749.8M
est $725.6M
+3.3%+0.7%
May 5, 2026$0.28
est $0.05
+460.0%$738.8M
est $694.6M
+6.4%+19.7%
Feb 2, 2026$0.47
est $0.45
+4.4%$704.8M
est $691.6M
+1.9%−4.6%
Oct 23, 2025$0.46
est $0.45
+2.2%$705.9M
est $685.1M
+3.0%+0.8%
Jul 24, 2025$0.46
est $0.46
0.0%$694.3M
est $701.7M
−1.1%−7.6%
Apr 24, 2025$0.46
est $0.46
0.0%$702.9M
est $689.2M
+2.0%−5.3%
Feb 3, 2025$0.05
est $0.05
0.0%$698.0M
est $698.3M
0.0%−2.9%
Oct 24, 2024$0.05
est $0.05
0.0%$700.4M
est $686.1M
+2.1%−3.6%

“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.

Healthpeak Properties stock forecast and analyst price targets

Analysts’ average 12-month price target for Healthpeak Properties is $22.95, +14.9% from the last close, from 11 firms rating the stock in the last 90 days.

$22.95consensus 12-month target, +14.9% from the last close
Low $21High $25
Buy2
Hold9
Sell0

Each firm’s latest rating in the last 90 days: 11 firms.

Latest analyst actions

DateFirmRatingTargetvs price
Nov 11UBSHold, reiterated$22+10.1%
Nov 9RBC CapitalBuy, maintained$24+20.1%
Nov 9Bank of America SecuritiesBuy, reiterated$25+25.1%
Nov 3Morgan StanleyHold, maintained$22+10.1%
Nov 3Wells FargoHold, maintained——
0.0%average 20-day move after past Neutral readings
+1.8%average move over the next 20 trading days in the last 5 years
±2.5%typical daily move, from the 14-day average range

Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.

Healthpeak Properties seasonality: the next 20 trading days

Over the next 20 trading days from Nov 14, Healthpeak Properties averaged +1.8% across the last 5 years, rising in 2 of them.

Next 20 trading days, by year

−0.4%2021+3.5%2022+13.3%2023−2.3%2024−4.0%2025

Average move and hit rate

WindowAverageYears higher
Next 5 trading days−0.1%2 of 5
Next 10 trading days+1.7%4 of 5
Next 15 trading days+1.7%3 of 5
Next 20 trading days+1.8%2 of 5
Next 30 trading days+2.1%2 of 5

For scale, DOC’s typical 20-trading-day move in either direction is about 5%.

Healthpeak Properties market cap and key statistics

Healthpeak Properties’s market cap is $13.78B, with a P/E ratio of 53.3 and revenue of $2.95B over the last twelve months.

Valuation

Market cap
$13.78B
P/E ratio
53.3
Forward P/E
169.5
EPS, TTM
$0.35
Gekko Fair Value
$25.95

Trading

Volume
4.82M
Avg volume, 20 days
6.14M
52-week high
$22.95
52-week low
$15.70
Shares outstanding
689.5M

Financials

Revenue, TTM
$2.95B
Profit margin
8.3%
Return on equity
3%
Quarterly earnings growth, YoY
+68.2%

Risk and income

Beta
0.99
Typical daily move
±2.5%
Typical 20-day move
±5%
Dividend yield
6.42%

Healthpeak Properties stock news this week

1 headline about Healthpeak Properties from the past week, newest first, each linking to the publisher.

More stocks

In the Buying zone today

Reporting earnings this week

Popular on Gekko

More stocks in Finance

Healthpeak Properties stock FAQ

What is Healthpeak Properties’s market cap?

Healthpeak Properties’s market cap is $13.78B at the Nov 13, 2026 close of $19.98, with 689.5M shares outstanding. The shares trade on a P/E ratio of 53.3.

What is the Healthpeak Properties stock forecast?

The consensus analyst 12-month price target for Healthpeak Properties is $22.95, +14.9% from the last close. Of the 11 firms that rated the stock in the last 90 days, 2 rate it a buy, 9 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.

Is Healthpeak Properties stock overvalued or undervalued?

On Gekko’s estimate Healthpeak Properties is undervalued: the Nov 13, 2026 close of $19.98 is 23.0% below Gekko Fair Value of $25.95. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.

When does Healthpeak Properties report earnings next?

Healthpeak Properties is expected to report on Feb 1, 2027 (78 days away). Analysts expect earnings of $0.04 per share on revenue of $762.2M. Healthpeak Properties beat the earnings estimate in 4 of its last 8 reports, moving 5.6% on average across the report.

What is Healthpeak Properties’s 52-week high and low?

Healthpeak Properties’s 52-week high is $22.95 and its 52-week low is $15.70; it closed at $19.98 on Nov 13, 2026, +13.3% over the past year. Over the last five years the shares peaked at $36.85 on Jan 5, 2022.

Is Healthpeak Properties stock a buy right now?

Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 3 of the 5 items with data read as supportive (trend, fair value and earnings risk), 2 as mixed (gekkoindex and seasonality). The checklist is a description of current data, not a recommendation.

How this page works

During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →

See Healthpeak Properties the way Gekko members do

Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.

Join 1,475 other traders using Gekko

Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.